Attenuation of antibody response to acute pyelonephritis by treatment with antibiotics.
While acute pyelonephritis is known to elicit an antibody response, it is also known that a patient who has had pyelonephritis once is susceptible to recurrent renal infection. Using our experimental model of pyelonephritis in the monkey, we tested whether antibiotic therapy of the acute disease would affect the antibody response. We found that it did, because antibiotic therapy beginning 72 h after bacterial inoculation attenuated the antibody response so that rechallenge 3 months later produced acute pyelonephritis and prolonged bacteriuria. The animals with untreated infection had an antibody response that lasted a sufficient period of time to prevent acute pyelonephritis after renal challenge. We have confirmed that antibody titers against P fimbriae are protective, and to a degree, this protective effect may be abrogated by antibiotic therapy.
Neal
D E
DE
Department of Urology, Tulane Regional Primate Research Center, Covington, Louisiana 70433.
Kaack
M B
MB
Baskin
G
G
Roberts
J A
JA
D000208:Acute Disease; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000917:Antibody Formation / Q000187:drug effects; D001437:Bacteriuria / Q000382:microbiology; D004797:Enzyme-Linked Immunosorbent Assay; D004927:Escherichia coli Infections / Q000276:immunology; D007677:Kidney Function Tests; D008252:Macaca fascicularis; D011704:Pyelonephritis / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology
D000900:Anti-Bacterial Agents